428 related articles for article (PubMed ID: 8622883)
21. Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1.
Schulze A; Zerfass K; Spitkovsky D; Henglein B; Jansen-Dürr P
Oncogene; 1994 Dec; 9(12):3475-82. PubMed ID: 7970707
[TBL] [Abstract][Full Text] [Related]
22. Involvement of retinoblastoma (Rb) and E2F transcription factors during photodynamic therapy of human epidermoid carcinoma cells A431.
Ahmad N; Gupta S; Mukhtar H
Oncogene; 1999 Mar; 18(10):1891-6. PubMed ID: 10086343
[TBL] [Abstract][Full Text] [Related]
23. Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1E132, but not by deletion of p16INK4A or p21WAF1/CIP1.
Halaban R; Cheng E; Zhang Y; Mandigo CE; Miglarese MR
Oncogene; 1998 May; 16(19):2489-501. PubMed ID: 9627115
[TBL] [Abstract][Full Text] [Related]
24. Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells.
Zhu WY; Jones CS; Kiss A; Matsukuma K; Amin S; De Luca LM
Exp Cell Res; 1997 Aug; 234(2):293-9. PubMed ID: 9260897
[TBL] [Abstract][Full Text] [Related]
25. Transforming growth factor-beta regulation of retinoblastoma gene product and E2F transcription factor during cell cycle progression in mouse fibroblasts.
Kim TA; Ravitz MJ; Wenner CE
J Cell Physiol; 1994 Jul; 160(1):1-9. PubMed ID: 8021288
[TBL] [Abstract][Full Text] [Related]
26. Caspase activation and changes in Bcl-2 family member protein expression associated with E2F-1-mediated apoptosis in human esophageal cancer cells.
Yang HL; Dong YB; Elliott MJ; Liu TJ; McMasters KM
Clin Cancer Res; 2000 Apr; 6(4):1579-89. PubMed ID: 10778992
[TBL] [Abstract][Full Text] [Related]
27. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
28. Functional roles of E2F in cell cycle regulation.
Fan J; Bertino JR
Oncogene; 1997 Mar; 14(10):1191-200. PubMed ID: 9121768
[TBL] [Abstract][Full Text] [Related]
29. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein.
Geng Y; Eaton EN; Picón M; Roberts JM; Lundberg AS; Gifford A; Sardet C; Weinberg RA
Oncogene; 1996 Mar; 12(6):1173-80. PubMed ID: 8649818
[TBL] [Abstract][Full Text] [Related]
30. Transient accumulation of retinoblastoma/E2F-1 protein complexes correlates with the onset of neuronal differentiation in the developing quail neural retina.
Kastner A; Espanel X; Brun G
Cell Growth Differ; 1998 Oct; 9(10):857-67. PubMed ID: 9790497
[TBL] [Abstract][Full Text] [Related]
31. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
32. Failure of T lymphocytes from elderly humans to enter the cell cycle is associated with low Cdk6 activity and impaired phosphorylation of Rb protein.
Arbogast A; Boutet S; Phelouzat MA; Plastre O; Quadri R; Proust JJ
Cell Immunol; 1999 Oct; 197(1):46-54. PubMed ID: 10555995
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression.
Geradts J; Kratzke RA; Niehans GA; Lincoln CE
Cancer Res; 1995 Dec; 55(24):6006-11. PubMed ID: 8521382
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional inhibition by the retinoblastoma protein.
Fattaey A; Helin K; Harlow E
Philos Trans R Soc Lond B Biol Sci; 1993 Jun; 340(1293):333-6. PubMed ID: 8103936
[TBL] [Abstract][Full Text] [Related]
35. Regulation of cellular genes in a chromosomal context by the retinoblastoma tumor suppressor protein.
Buchmann AM; Swaminathan S; Thimmapaya B
Mol Cell Biol; 1998 Aug; 18(8):4565-76. PubMed ID: 9671466
[TBL] [Abstract][Full Text] [Related]
36. Loss of the p16/MTS1 tumor suppressor gene causes E2F-mediated deregulation of essential enzymes of the DNA precursor metabolism.
Hengstschläger M; Pusch O; Hengstschläger-Ottnad E; Ambros PF; Bernaschek G; Wawra E
DNA Cell Biol; 1996 Jan; 15(1):41-51. PubMed ID: 8561896
[TBL] [Abstract][Full Text] [Related]
37. The mitogenic effect of parathyroid hormone is associated with E2F-dependent activation of cyclin-dependent kinase 1 (cdc2) in osteoblast precursors.
Onishi T; Zhang W; Cao X; Hruska K
J Bone Miner Res; 1997 Oct; 12(10):1596-605. PubMed ID: 9333120
[TBL] [Abstract][Full Text] [Related]
38. Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16Ink4.
Tam SW; Shay JW; Pagano M
Cancer Res; 1994 Nov; 54(22):5816-20. PubMed ID: 7954407
[TBL] [Abstract][Full Text] [Related]
39. Complex structure and regulation of the P16 (MTS1) locus.
Stone S; Jiang P; Dayananth P; Tavtigian SV; Katcher H; Parry D; Peters G; Kamb A
Cancer Res; 1995 Jul; 55(14):2988-94. PubMed ID: 7606716
[TBL] [Abstract][Full Text] [Related]
40. E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest.
Mann DJ; Jones NC
Curr Biol; 1996 Apr; 6(4):474-83. PubMed ID: 8723352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]